APO RESEARCH · REPORT
Blood Culture Test
Blood cultures are used to detect the presence of bacteria or fungi in the blood, to identify the type present, and to guide treatment. Testing is used to identify a blood infection (septicemia) that can lead to sepsis, a serious and life-threatening complication. Individuals with a suspected blood infection are often treated in intensive care units, so testing is often done in a hospital setting.
Product & engineering
Understand the product.
Blood cultures are used to detect the presence of bacteria or fungi in the blood, to identify the type present, and to guide treatment. Testing is used to identify a blood infection (septicemia) that can lead to sepsis, a serious and life-threatening complication. Individuals with a suspected blood infection are often treated in intensive care units, so testing is often done in a hospital setting.
Selected research
Market Outlook & Growth Opportunities
Global Blood Culture Test Market Outlook and Growth Opportunities 2026
Market perspective
Blood cultures are used to detect the presence of bacteria or fungi in the blood, to identify the type present, and to guide treatment. Testing is used to identify a blood infection (septicemia) that can lead to sepsis, a serious and life-threatening complication. Individuals with a suspected blood infection are often treated in intensive care units, so testing is often done in a hospital setting.
Market competition is not intense. In United States market, BD, Biomerieux, Roche, Abbott, Beckman Coulter, Thermo Fisher, Siemens, Bruker, Cepheid, Alere, etc. are the leaders of the industry, and they hold key technologies and patents, with 90% market share.
This report provides an overview of the global Blood Culture Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Blood Culture Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Blood Culture Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Blood Culture Test market.
Blood Culture Test Segment by Company
BD
Biomerieux
Roche
Abbott
Beckman Coulter
Thermo Fisher
Siemens
Bruker
Cepheid
Alere
Blood Culture Test Segment by Type
Instruments
Consumables
Others
Blood Culture Test Segment by Application
Hospital Laboratories
Reference Laboratories
Others
Blood Culture Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Blood Culture Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Blood Culture Test key companies, revenue, market share, and recent developments.
3. To split the Blood Culture Test breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Blood Culture Test market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Blood Culture Test significant trends, drivers, influence factors in global and regions.
6. To analyze Blood Culture Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Culture Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Culture Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Culture Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Culture Test industry.
Chapter 3: Detailed analysis of Blood Culture Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Blood Culture Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Blood Culture Test in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Instruments
- Consumables
- Others
Applications
- Hospital Laboratories
- Reference Laboratories
- Others
Companies covered
- BD
- Biomerieux
- Roche
- Abbott
- Beckman Coulter
- Thermo Fisher
- Siemens
- Bruker
- Cepheid
- Alere
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Blood Culture Test Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Blood Culture Test Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Blood Culture Test Market Dynamics
- 2.1 Blood Culture Test Industry Trends
- 2.2 Blood Culture Test Industry Drivers
- 2.3 Blood Culture Test Industry Opportunities and Challenges
- 2.4 Blood Culture Test Industry Restraints
3 Blood Culture Test Market by Company
- 3.1 Global Blood Culture Test Company Revenue Ranking in 2025
- 3.2 Global Blood Culture Test Revenue by Company (2021-2026)
- 3.3 Global Blood Culture Test Company Ranking (2024-2026)
- 3.4 Global Blood Culture Test Company Manufacturing Base and Headquarters
- 3.5 Global Blood Culture Test Company Product Type and Application
- 3.6 Global Blood Culture Test Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Blood Culture Test Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Blood Culture Test Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Blood Culture Test Market by Type
- 4.1 Blood Culture Test Type Introduction
- 4.1.1 Instruments
- 4.1.2 Consumables
- 4.1.3 Others
- 4.2 Global Blood Culture Test Sales Value by Type
- 4.2.1 Global Blood Culture Test Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Blood Culture Test Sales Value by Type (2021-2032)
- 4.2.3 Global Blood Culture Test Sales Value Share by Type (2021-2032)
5 Blood Culture Test Market by Application
- 5.1 Blood Culture Test Application Introduction
- 5.1.1 Hospital Laboratories
- 5.1.2 Reference Laboratories
- 5.1.3 Others
- 5.2 Global Blood Culture Test Sales Value by Application
- 5.2.1 Global Blood Culture Test Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Blood Culture Test Sales Value by Application (2021-2032)
- 5.2.3 Global Blood Culture Test Sales Value Share by Application (2021-2032)
6 Blood Culture Test Regional Value Analysis
- 6.1 Global Blood Culture Test Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Blood Culture Test Sales Value by Region (2021-2032)
- 6.2.1 Global Blood Culture Test Sales Value by Region: 2021-2026
- 6.2.2 Global Blood Culture Test Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Blood Culture Test Sales Value (2021-2032)
- 6.3.2 North America Blood Culture Test Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Blood Culture Test Sales Value (2021-2032)
- 6.4.2 Europe Blood Culture Test Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Blood Culture Test Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Blood Culture Test Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Blood Culture Test Sales Value (2021-2032)
- 6.6.2 South America Blood Culture Test Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Blood Culture Test Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Blood Culture Test Sales Value Share by Country, 2025 VS 2032
7 Blood Culture Test Country-level Value Analysis
- 7.1 Global Blood Culture Test Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Blood Culture Test Sales Value by Country (2021-2032)
- 7.2.1 Global Blood Culture Test Sales Value by Country (2021-2026)
- 7.2.2 Global Blood Culture Test Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.7.2 France Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.14.2 China Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.17.2 India Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Blood Culture Test Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Blood Culture Test Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Blood Culture Test Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Blood Culture Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 BD
- 8.1.1 BD Company Information
- 8.1.2 BD Business Overview
- 8.1.3 BD Blood Culture Test Revenue and Gross Margin (2021-2026)
- 8.1.4 BD Blood Culture Test Product Portfolio
- 8.1.5 BD Recent Developments
- 8.2 Biomerieux
- 8.2.1 Biomerieux Company Information
- 8.2.2 Biomerieux Business Overview
- 8.2.3 Biomerieux Blood Culture Test Revenue and Gross Margin (2021-2026)
- 8.2.4 Biomerieux Blood Culture Test Product Portfolio
- 8.2.5 Biomerieux Recent Developments
- 8.3 Roche
- 8.3.1 Roche Company Information
- 8.3.2 Roche Business Overview
- 8.3.3 Roche Blood Culture Test Revenue and Gross Margin (2021-2026)
- 8.3.4 Roche Blood Culture Test Product Portfolio
- 8.3.5 Roche Recent Developments
- 8.4 Abbott
- 8.4.1 Abbott Company Information
- 8.4.2 Abbott Business Overview
- 8.4.3 Abbott Blood Culture Test Revenue and Gross Margin (2021-2026)
- 8.4.4 Abbott Blood Culture Test Product Portfolio
- 8.4.5 Abbott Recent Developments
- 8.5 Beckman Coulter
- 8.5.1 Beckman Coulter Company Information
- 8.5.2 Beckman Coulter Business Overview
- 8.5.3 Beckman Coulter Blood Culture Test Revenue and Gross Margin (2021-2026)
- 8.5.4 Beckman Coulter Blood Culture Test Product Portfolio
- 8.5.5 Beckman Coulter Recent Developments
- 8.6 Thermo Fisher
- 8.6.1 Thermo Fisher Company Information
- 8.6.2 Thermo Fisher Business Overview
- 8.6.3 Thermo Fisher Blood Culture Test Revenue and Gross Margin (2021-2026)
- 8.6.4 Thermo Fisher Blood Culture Test Product Portfolio
- 8.6.5 Thermo Fisher Recent Developments
- 8.7 Siemens
- 8.7.1 Siemens Company Information
- 8.7.2 Siemens Business Overview
- 8.7.3 Siemens Blood Culture Test Revenue and Gross Margin (2021-2026)
- 8.7.4 Siemens Blood Culture Test Product Portfolio
- 8.7.5 Siemens Recent Developments
- 8.8 Bruker
- 8.8.1 Bruker Company Information
- 8.8.2 Bruker Business Overview
- 8.8.3 Bruker Blood Culture Test Revenue and Gross Margin (2021-2026)
- 8.8.4 Bruker Blood Culture Test Product Portfolio
- 8.8.5 Bruker Recent Developments
- 8.9 Cepheid
- 8.9.1 Cepheid Company Information
- 8.9.2 Cepheid Business Overview
- 8.9.3 Cepheid Blood Culture Test Revenue and Gross Margin (2021-2026)
- 8.9.4 Cepheid Blood Culture Test Product Portfolio
- 8.9.5 Cepheid Recent Developments
- 8.10 Alere
- 8.10.1 Alere Company Information
- 8.10.2 Alere Business Overview
- 8.10.3 Alere Blood Culture Test Revenue and Gross Margin (2021-2026)
- 8.10.4 Alere Blood Culture Test Product Portfolio
- 8.10.5 Alere Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst